stars 1 stars 2 stars 3

Insuvia is designed to act as a pharmacovigilance and regulatory affairs unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional and country-level expertise to solve all pharmacovigilance and regulatory affairs challenges that pharmaceutical companies encounter while commercializing their products. PHARMACOVIGILANCE SERVICES We ensure product safety and regulatory compliance across the entire product lifecycle, from clinical trial safety to post-approval pharmacovigilance. With a strong local presence in key markets, we provide comprehensive services, including essential EU-QPPV office support, as well as LPPVs and local PV services across global territories. This enables our clients to maintain the highest safety standards and meet all regulatory requirements both globally and locally. REGULATORY AFFAIRS SERVICES We guide biopharmaceutical companies through the regulatory landscape, ensuring compliance at every stage of the product lifecycle. We offer strategic planning, expert regulatory guidance, and risk mitigation through due diligence and compliance management. With country-specific expertise, we help clients navigate local regulations, ensuring local regulatory compliance and accelerating market access. LOCAL AFFILIATE SERVICES We provide unmatched local expertise in all compliance areas, fully substituting and enhancing traditional biopharma affiliate functions. As the sole point of contact for all local compliance needs, we simplify and streamline support for biopharma companies. This distinctive capability makes us the only provider with such extensive and effective coverage.

Insuvia Questions

The Insuvia annual revenue was $11 million in 2026.

Donatas Grina is the CEO of Insuvia.

39 people are employed at Insuvia.

The NAICS codes for Insuvia are [325, 32].

The SIC codes for Insuvia are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users